Nutriband, Inc. (NTRB)
5.71
-0.39
(-6.39%)
USD |
NASDAQ |
Sep 09, 15:46
Nutriband Total Liabilities (Quarterly) : 0.9644M for July 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 0.9644M |
| April 30, 2026 | 0.9023M |
| January 31, 2026 | 0.8684M |
| October 31, 2025 | 0.8702M |
| July 31, 2025 | 1.683M |
| April 30, 2025 | 1.049M |
| January 31, 2025 | 1.041M |
| October 31, 2024 | 1.312M |
| July 31, 2024 | 1.173M |
| April 30, 2024 | 1.791M |
| January 31, 2024 | 1.079M |
| October 31, 2023 | 2.812M |
| July 31, 2023 | 2.982M |
| April 30, 2023 | 0.9558M |
| January 31, 2023 | 0.8834M |
| October 31, 2022 | 0.9376M |
| July 31, 2022 | 0.9852M |
| April 30, 2022 | 0.9044M |
| January 31, 2022 | 0.8804M |
| October 31, 2021 | 1.109M |
| July 31, 2021 | 2.848M |
| April 30, 2021 | 2.724M |
| Date | Value |
|---|---|
| January 31, 2021 | 2.816M |
| October 31, 2020 | 2.826M |
| July 31, 2020 | 0.9026M |
| April 30, 2020 | 0.7259M |
| January 31, 2020 | 2.022M |
| October 31, 2019 | 1.368M |
| July 31, 2019 | 0.72M |
| April 30, 2019 | 0.4354M |
| January 31, 2019 | 0.403M |
| October 31, 2018 | 0.2011M |
| July 31, 2018 | 0.1621M |
| April 30, 2018 | 0.1598M |
| January 31, 2018 | 0.0434M |
| October 31, 2017 | 0.0347M |
| July 31, 2017 | 0.0179M |
| April 30, 2017 | 0.0223M |
| January 31, 2017 | 0.0146M |
| October 31, 2016 | 0.0463M |
| July 31, 2016 | 0.034M |
| April 30, 2016 | 0.0254M |
| January 31, 2016 | 0.0118M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.293M |
| Shareholders Equity (Quarterly) | 5.329M |
| Debt to Equity Ratio | 0.0412 |
| Current Ratio | 4.211 |
| Net Debt Paydown Yield | 0.04% |